Evidence for P53 as Guardian of the Cardiomyocyte Mitochondrial Genome Following Acute Adriamycin Treatment

Journal of Histochemistry and Cytochemistry - United States
doi 10.1369/jhc.6a7146.2007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

P53: Guardian of a Genome's Guardian?

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2003English

Adriamycin in the Treatment of Acute Leukaemia

BMJ
1972English

P53 and Disease: When the Guardian Angel Fails

Cell Death and Differentiation
Cell BiologyMolecular Biology
2006English

PRKDC Participates in Mitochondrial Genome Maintenance and Prevents Adriamycin-Induced Nephropathy in Mice

Journal of Clinical Investigation
Medicine
2010English

The Need for Evidence Based Nutritional Guidelines for Pediatric Acute Lymphoblastic Leukemia Patients: Acute and Long-Term Following Treatment

Nutrients
NutritionFood ScienceDietetics
2013English

Mitochondrial Fission Is Required for Angiotensin II-Induced Cardiomyocyte Apoptosis Mediated by a Sirt1-P53 Signaling Pathway

Frontiers in Pharmacology
Pharmacology
2018English

Acute Promyelocytic Leukemia Following Mitoxantrone as Single Agent for the Treatment of Multiple Sclerosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Microsatellite Instability in the Mitochondrial DNA of Colorectal Carcinomas: Evidence for Mismatch Repair Systems in Mitochondrial Genome

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

The "Guardian of the Genome" - An Old Key to Unlock the ERCC1 Issue

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy